LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
LLY
936.53
+0.86%↑
JNJ
186.34
-0.01%↓
UNH
321.47
-2%↓
NVS
126.4
+0.75%↑
ABT
124.91
+0.22%↑
24h
Current
Min
2.41
Max
2.52
Recommendations | Buy |
|---|---|
12 Months Forecast | +484.68% upside |
Next Earnings | 12 lis 2025 |
|---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
1 paź 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Read
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 14.5 USD 484.68%
High 17 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$